Zaprinast, cicletanine, and verapamil attenuate overdrive pacing-induced myocardial ischemia in conscious rabbits

Life Sci. 1993;53(1):PL13-8. doi: 10.1016/0024-3205(93)90617-c.

Abstract

In conscious rabbits equipped with right ventricular electrode and left ventricular polyethylene catheters, zaprinast and cicletanine, inhibitors of phosphodiesterase (PDE) V and PDEs I and V, respectively, as well as verapamil, a Ca2+ channel blocker, decreased intracavital ST-segment elevation induced by ventricular overdrive pacing (VOP). Zaprinast and cicletanine attenuated VOP-induced QT reduction and increase in left ventricular end-diastolic pressure (LVEDP), whereas verapamil increased LVEDP. These results suggest that inhibition of cGMP-PDEs can protect heart against ischemia.

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors*
  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors*
  • Animals
  • Cardiac Pacing, Artificial
  • Electrocardiography
  • Heart Ventricles / drug effects
  • Hemodynamics
  • Male
  • Myocardial Ischemia / drug therapy*
  • Myocardial Ischemia / physiopathology
  • Purinones / therapeutic use*
  • Pyridines / therapeutic use*
  • Rabbits
  • Verapamil / therapeutic use*

Substances

  • Purinones
  • Pyridines
  • cicletanine
  • Verapamil
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • zaprinast